Govt should move quickly to ramp up vaccine availability: Sangita Reddy

The government should move quickly to ramp up the availability of the Covid-19 vaccine in the country by enhancing domestic production, says Apollo Hospitals Joint MD Sangita Reddy

Sangita Reddy
Sangita Reddy
Press Trust of India New Delhi
2 min read Last Updated : May 17 2021 | 7:08 PM IST

The government should move quickly to ramp up the availability of the COVID-19 vaccine in the country by enhancing domestic production as well as increasing procurement from abroad, Apollo Hospitals Joint MD Sangita Reddy said on Monday.

Reddy also urged the government to utilise all public and private hospitals at the district level for vaccination purposes.

"The challenge of India#vaccinationstrategy is not admin as much as supply. I urge R #govt to move quickly on ramping up domestic prod, enhance intl procure, seek Intl aid in the form of vaccine & establish a dist network of all Pub & Pvt hospitals 2 accelerate the pace of inoculation," Reddy said in a post on micro-blogging site Twitter.

Last week, Reddy had suggested the government to take decisive actions to ramp up the production of COVID vaccines and streamline the inoculation processes to include citizens who do not have access to the internet.

"I urge @PMOIndia 2 take Bold & decisive actions to ramp up #COVID #vaccines & streamline inoculation processes to include citizens who do not have access 2 #internet/ #cowin app Allowing #walkin regis at #vaccination centres will help #VaccinationDrive, " she had tweeted.

Reddy was reacting to a report that India's technocratic approach to vaccination is excluding the digitally-deprived.

The Union Health Ministry on Monday said more than two crore COVID-19 vaccine doses are still available with the states and Union territories, while nearly three lakh doses are in the pipeline and will be received by them within the next three days.

The Centre has so far provided over 20 crore (20,76,10,230) vaccine doses to the states and Union territories for free.

Of this, the total consumption, calculated based on average figures, up to May 16, including wastage, is 18,71,13,705 doses (according to data available at 8 am on Monday).

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusApollo Hospitals EnterpriseCoronavirus Vaccine

First Published: May 17 2021 | 7:05 PM IST

Next Story